Skip to main content
AAN.com
Article
November 1, 1972

Coagulation defects caused by diphenylhydantoin

November 1972 issue
22 (11) 1165
First page of PDF

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 22Number 11November 1972
Pages: 1165
PubMed: 4673559

Publication History

Published online: November 1, 1972
Published in print: November 1972

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Gail E. Solomon, M.D.
Departments of Neurology and Pediatrics (Division of Hematology), Cornell University Medical College, New York City.
Margaret W. Hilgartner, M.D.
Departments of Neurology and Pediatrics (Division of Hematology), Cornell University Medical College, New York City.
Henn Kutt, M.D.
Departments of Neurology and Pediatrics (Division of Hematology), Cornell University Medical College, New York City.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Epilepsy and Pregnancy, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 6, 3, (345-349), (2015).https://doi.org/10.1017/S0317167100023982
    Crossref
  2. The clinical pharmacokinetics of phenytoin, Journal of Pharmacokinetics and Biopharmaceutics, 5, 6, (579-596), (2015).https://doi.org/10.1007/BF01059685
    Crossref
  3. Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis, Thrombosis Research, 133, 5, (729-735), (2014).https://doi.org/10.1016/j.thromres.2014.01.037
    Crossref
  4. Intracerebral Hemorrhage, Toole's Cerebrovascular Disorders, (217-233), (2013).https://doi.org/10.1017/CBO9781139644235.019
    Crossref
  5. Hematological Disorders and Hypercoagulable States, Toole's Cerebrovascular Disorders, (160-176), (2013).https://doi.org/10.1017/CBO9781139644235.014
    Crossref
  6. The Risk-Benefit Ratio of Anticonvulsant Drugs, Medical Toxicology, 2, 5, (324-337), (2012).https://doi.org/10.1007/BF03259952
    Crossref
  7. A Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 17, 5, (917-928), (2012).https://doi.org/10.1002/j.1875-9114.1997.tb03782.x
    Crossref
  8. Outcome of Epileptic Pregnancy: Neonatal Hemorrhage due to Anticonvulsant Treatment of Mothers during Pregnancy, Asia-Oceania Journal of Obstetrics and Gynaecology, 14, 3, (355-366), (2010).https://doi.org/10.1111/j.1447-0756.1988.tb00117.x
    Crossref
  9. Phenytoin, Human Developmental Toxicants, (243-254), (2009).https://doi.org/10.1201/9781420006759.ch42
    Crossref
  10. Binder's syndrome due to prenatal vitamin K deficiency: A theory of pathogenesis, Australian Dental Journal, 37, 6, (453-460), (2009).https://doi.org/10.1111/j.1834-7819.1992.tb05901.x
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share